// App-Quantinova.ai

EP373 : FUNCTIONAL COOPERATION OF CEBPA AND TET2 MUTATIONS IN ACUTE MYELOID LEUKEMIA

Researchers

Presenter

  • Elizabeth Heyes

Principal Investigators

  • Anna S Wilhelmson

  • Anne Wenzel

  • Mikkel B Schuster

  • Mina Ali

  • Teresa D'Altri

  • Thomas Eder

  • Gabriele Manhart

  • Edwin Rzepa

  • Luisa Schmidt

  • Manja Meggendorfer

  • Torsten Haferlach

  • Giacomo Volpe

  • Claus Nerlov

  • Jon Frampton

  • Kyoung Jae Won

  • Florian Grebien

  • Bo T Porse

Medical Centers

  • Roche Austria GmbH, Vienna, Austria

  • Laboratory of Integrative Biology, Guangzhou Institutes of Biomedicine and Health,Chinese Academy of Sciences,Guangzhou,China

  • Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences,University of Birmingham,Birmingham,United Kingdom

  • Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark

  • Munich Leukemia Laboratory, Munich, Germany.

  • MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom

  • The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark

  • Institute for Medical Biochemistry,University for Veterinary Medicine Vienna,Vienna,Autriche

  • Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health Sciences,University of Copenhagen,Copenhagen,Danemark

Locations

  • Austria

  • China

  • United Kingdom

  • Denmark

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • CCAAT enhancer binding protein alpha

  • Tet methylcytosine dioxygenase 2

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A